[1] KUMAWAT V,SHARMA R,MALHOTRA P,et al.Prevalence of risk factors for platelet transfusion refractoriness in multitransfused hemato-oncological patients at tertiary care center in North India[J]. Asian J Transfus Sci,2015,9(1):61. [2] 聂锋,练正秋,李玲.血小板抗体检测分析与探讨[J].中国实验诊断学,2019,23(12):2052-2054. [3] 袁慧铭,邓永乐,陈志龙,等. 血型、性别及输血次数与血小板抗体阳性率关系的探讨[J]. 中国输血杂志,2017,30(7):742-744. [4] KREUGER A L,MÄKELBURG A B U,SOMERS J A E, et al.HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening[J]. Transfusion,2019,59(11):3303-3307. [5] 龚道方,龙海波,刘昭国,等.临床276例次单采血小板输注效果及相关因素分析[J].临床输血与检验,2018,20(4):365-368. [6] 魏亚明,桂嵘,王秋实,等.血小板抗体检测专家共识[J]. 临床输血与检验,2020,22(1):1-5. [7] 沈溪英,孙德英,李华,等.输注血小板后血小板抗体检出率与输注反应的关系[J].上海医学检验杂志,1997,12(1):17-18. [8] 杨乾坤,陈李影慧.多次输血患者血小板抗体检测与血小板输注疗效相关性研究[J].中国输血杂志,2017,30(12):1363-1365. [9] 郭凯,王笑欢,张慧敏,等. 两种血小板抗体试剂在儿童患者应用的一致性评价[J].北京医学,2019,41(10):929-931. [10] 张秋会,张婧,刘丽娜,等.多次输血后患者血小板输注无效的血小板抗体检测与分析[J].临床输血与检验,2015,17(5):409-412. [11] 冯红梅,蔡祥胜,杨兆收,等.血小板抗体产生的影响因素分析[J]. 广东药科大学学报,2019,35(5):674-678. [12] JIA Y,LI W,LIU N,et al.Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients[J]. Transfusion Med,2014,24(6):406-410. [13] PAVENSKI K,FREEDMAN J,SEMPLE J W.HLA alloimmunization against platelet transfusions:pathophysiology,significance,prevention and management[J]. Tissue Antigens,2012,79(4):237-245. [14] 韩文导,罗华山,魏明燕.反复输血患者的血小板抗体检测分析及其意义[J].临床血液学杂志(输血与检验),2017,30(4):618-620. [15] 张趁利,庞桂芝,娄白敏,等.反复输血患者的血小板抗体检测及配型前后的疗效对比[J].临床输血与检验,2014,16(1):66-68. [16] 陆乐,李平,刘婷婷,等.不同性别、临床科室患者血小板抗体筛查结果分析[J].国际检验医学杂志,2021,42(3):263-265. |